no results
Ihre Produkte genau hier!
Ihre Suche lieferte keine Ergebnisse, aber Sie können sich mit Ihren Produkten und Leistungen auf dieser Seite präsentieren
Mit einem Eintrag auf Weltzentrum der Medizintechnik platzieren Sie Ihre Produkte und Dienstleistungen bei Google & Co. ganz weit oben und erreichen so jeden Tag mehrere Tausend potentielle Kunden aus der Medizintechnikbranche. Mehr Informationen gibt es auf der Firma eintragen - Seite.
no results
Ihr Unternehmen genau hier!
Ihre Suche lieferte keine Ergebnisse, aber Sie können sich auf dieser Seite präsentieren
Mit einem Eintrag auf Weltzentrum der Medizintechnik platzieren Sie Ihr Unternehmen bei Google & Co. ganz weit oben und erreichen so jeden Tag mehrere Tausend potentielle Kunden aus der Medizintechnikbranche. Mehr Informationen gibt es auf der Firma eintragen - Seite.
Adhesion barriers
The increasing incidence of chronic diseases and increased geriatric population in the APAC region have created an increasing need for adhesion barriers. These medical devices reduce the risk of post-operative complications, and the market for such products is expected to grow significantly in the coming years. Various companies are developing biomaterials to develop anti-adhesion barriers, including Oxiplex/AP Absorbable Adhesion Barrier Gel, which is a temporary mechanical barrier made of a company's proprietary biomaterial. The gel is supplied in two 20-mL syringes, and a sterile applicator for ease of application.
The global adhesion barriers market is segmented into North America, Europe, Asia Pacific, Latin America, and Africa. In terms of geographic regions, APAC has the highest potential for growth due to its large population and growing prevalence of chronic diseases. Also, with an aging population and an increase in medical tourism, APAC and the Middle East are expected to have high growth rates for this product. This means that these regions are prime locations for companies to enter the market.
According to Transparency Market Research, the Seprafilm segment is set to account for a substantial share of the global market during the forecast period. This segment has been clinically proven to reduce postoperative adhesion. The 4DryField PH segment is anticipated to grow at a high CAGR during the forecast period. The product is a sterile, non-irritating gel that is approved by the European Medicines Agency as an anti-adhesion agent. In addition, it is frequently used during abdominal surgical procedures.
Some of the major players in the global adhesion barriers market are Baxter International, Johnson & Johnson, Integra LifeSciences, and Anika Therapeutics. The company plans to raise another $125,000 to develop its products. Several other leading companies are developing their own products. The company is developing newer types of adhesive barrier technologies that will be more effective and more affordable. The film-type adhesion barrier is expected to be the preeminent product category in the coming years.
In the current market, the majority of adhesion barriers are used in neurosurgical procedures. The most lucrative segments in the market are cardiovascular, gynecological, and urological surgeries. The gynecological surgery segment is expected to increase at a high CAGR during the forecast period. As a result, the market for adhesion barriers is likely to increase in the coming years. There is a high risk of infection during a surgical procedure.
The global adhesion barrier market is segmented based on the location where the surgical procedures are performed. Hospitals account for a large share of the market and are expected to grow at a high CAGR during the forecast period. Ambulatory surgical centers are expected to experience the fastest growth, but other segments are projected to grow at a slower pace than hospitals. In addition to hospitals, the market also includes gynecological surgery, and neurological surgery.
The demand for adhesion barriers is expected to rise in North America and Western Europe. The market is dominated by the United States and Europe due to the early adoption of the technology. The U.S. has approximately nine million surgeries per year, including 1.5 million spine surgeries. The European market for adhesion barriers is expected to grow at a faster pace than the global market for biomaterials. This region is the largest consumer of adhesives in the world, and has the largest market size.
The market for adhesion barriers is expected to grow at a rapid pace during the next five years. The market is expected to grow at a 7.8% CAGR. Innocoll Holdings PLC, MAST Biosurgery, Inc., and Integra LifeSciences Holdings Corporation are some of the prominent players in the adhesion barrier market. Several other major companies in the market include Baxter International, Inc. and Integra LifeSciences Holdings, Inc.
The worldwide market for adhesion barriers is projected to reach USD 769 million by 2025. The US is projected to be the dominant region by 2025, with an estimated CAGR of 6.3% over the forecast period. The Asian-Pacific is expected to grow at a 7.7% CAGR during the same period. The growth of the market is anticipated to be driven by the growing awareness of the disease among consumers. By the end of 2027, the global market is expected to register a double-digit CAGR.